Advertisement
Organisation › Details
Oxford Cancer Biomarkers Ltd.
Oxford Cancer Biomarkers translates ground-breaking scientific discovery into predictive biomarker diagnostic products that allow medicines to be personalised for the benefit of the cancer patient. Oxford Cancer Biomarkers is a spin-out of the University of Oxford and has strong links with the Medical Sciences Division in Oxford University. The company was founded by Nick La Thangue, Ph.D., Chair of Cancer Biology at Oxford University and David Kerr, CBE, D.Sc., M.D. FMedSci, Professor of Cancer Medicine at Oxford University. Investors in OCB include Longwall Venture Partners LLP, Esperante BV and the University. *
Start | 2012-01-18 splitoff | |
Group | Iqvia (Group) | |
Predecessor | University of Oxford | |
Industry | biomarker | |
Industry 2 | oncology | |
Person | Browning, David (Oxford Cancer Biomarker 201901 CEO + OBN Board Member before BioCity/MediCity + Philips + Amersham) | |
Person 2 | Sblendorio, Glenn (The Medicines Co 200603 CFO before Eyetech Pharma) | |
Region | Oxford, Oxfordshire | |
Country | United Kingdom (GB) | |
Street | Robert Robinson Avenue Oxford Science Park, Magdalen Centre | |
City | OX4 4GA Oxford, Oxfordshire | |
Tel | +44-1865-784743 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Oxford Cancer Biomarkers Ltd.. (4/19/17). "Press Release: Oxford Cancer Biomarkers Announces Strategic Collaboration with My-BioMed Biotechnology Co. Ltd.". Oxford. | ||
Record changed: 2023-07-10 |
Advertisement
More documents for Iqvia (Group)
- [1] Zetta Genomics Ltd.. (7/5/23). "Press Release: Zetta Genomics Appoints First Chief Revenue Officer"....
- [2] KCR S.A.. (1/13/20). "Press Release: KCR Announces New Chief Commercial Officer. Bryan Katz Joins KCR’s Growing Executive Team to Take Over as Head of Commercial Strategy and Global Partnerships". Boston, MA....
- [3] BC Platforms AG. (12/18/19). "Press Release: BC Platforms Closes $15 Million Series C Financing and Signs Partnership with Iqvia to Extend Data Analytics in Genomics". Zürich & Boston, MA....
- [4] OBN (UK) Ltd.. (1/2/19). "Press Release: OBN Appoints New Chairman and Non-Executive Director to Enhance Board Expertise". Abingdon....
- [5] Iqvia. (10/4/18). "Press Release: Iqvia and Genomics England Launch the First Real-World Research Platform with Integrated Clinical and Genomic Data". Danbury, CT & Research Triangle Park, NC....
- [6] Iqvia. (4/30/18). "Press Release: Recordati Selects Iqvia’s OCE Technology Platform and OneKey Information Services". Danbury, CT & Research Triangle Park, NC....
- [7] Clinerion AG. (3/19/18). "Press Release: Ian Rentsch Is Clinerion’s New CEO". Basel....
- [8] Iqvia. (11/6/17). "Press Release: QuintilesIMS Is Now Iqvia". Danbury, CT & Research Triangle Park, NC....
- [9] Oxford Immunotec Global plc. (8/30/17). "Press Release: Oxford Immunotec Appoints Stefan Linn as Chief Operating Officer". Oxford & Marlborough, MA....
- [10] Cluster für Individualisierte ImmunIntervention (Ci3) e. V.. (8/1/17). "Press Release: Collaboration Project between German Biotech and IT Companies Selected for Funding in First PERMIDES Round of Call"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top